Three Hungarian hospitals to spend HUF 7bn on development
2010-02-23
The hospitals in Kisvarda, Mateszalka and Fehergyarmat have applied for HUF 7bn (€25.8m) in total for development from the Social Infrastructure Operational Programme.
The hospital in Kisvarda is planning to implement a project worth HUF 3.3bn (€12.2m). This will include the construction of a two-storey technological centre with a sterilisation unit, a 7-bed intensive care unit and four operating theatres. The new building will be connected to the emergency unit and will use the most modern medical equipment.
The hospital in Mateszalka intends to invest HUF 2.5bn (€9.3m) in the establishment of outpatient clinics, inpatient neurology, gynaecological, and stroke units, a fitness room and an operating theatre.
Szatmar-Bereg hospital and spa aims to renovate its central technological unit and operating theatre. The institute also intends to purchase new equipment. The total cost of the development is estimated to be HUF 1.2bn (€4.4m).
1 year subscription to internet service providing market news and analytical articles
Central Europe Pharma Online provides news, articles and market data on the pharmaceutical market in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, from manufacturers and distributors to medical devices and research developments. Over 70 industry updates, covering manufacturers and distributors, medical news and research developments, together with news on laws and regulations governing the pharmaceutical sector are added on a regular basis. For timely news delivery, custom newsletters can be sent directly to your e-mail account, with content personalisation.
Subscription 1 year
Language: English
Delivery: online access
12-month subscription (26 issues of biweekly news)
Central Europe Pharma News is a bi-weekly newsletter delivered in PDF format directly to your inbox. Each edition of the newsletter delivers news and analysis of the pharmaceutical sector in Bulgaria, Czech Republic, Hungary, Romania, Poland and Slovakia, including an in-depth feature on the pharmaceutical industry in the Central & Eastern Europe region written by PMR market analysts. A list of upcoming events relevant to the region and a company index are included in every issue.
Date: Periodic publication
Language: English
Delivery: PDF file
PMRis a British-American company providing market information, advice and services to international businesses interested in Central and Eastern Europe as well as other emerging markets. PMR key areas of operation include business publications (through PMR Publications), consultancy (through PMR Consulting) and market research (through PMR Research). Being present on the market since 1995, employing highly skilled staff, offering high international standards in projects and publications, providing one of most frequently visited and top-ranked websites, PMR is one of the largest companies of its type in the region.
PMR Online Access
Browse and search in our archive »
Subscribe to PMR RSS NEWS channels » 
